Eurofins Scientific SE Stock
Stocks
ERF
FR0014000MR3
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
After hours 01:05:50 | |||
| 69.30 EUR | +0.43% |
|
69.18 | -0.17% |
| 06-30 | NFL Biosciences validates industrial-scale production of NFL-102 for smoking cessation |  |
| 06-05 | Eurofins Scientific SE acquired High North Laboratories. | CI |
| Market Cap | 12.06B 13.79B 11.12B 10.22B 19.37B 1,327B 19.71B 133B 52.1B 649B 51.79B 50.66B 2,236B | P/E 2026 * |
24x | P/E 2027 * | 18.4x |
|---|---|---|---|---|---|
| Enterprise Value | 15.5B 17.73B 14.3B 13.14B 24.9B 1,706B 25.33B 171B 66.98B 834B 66.58B 65.12B 2,874B | EV / Sales 2026 * |
2.04x | EV / Sales 2027 * | 1.88x |
| Free-Float |
58.35% | Yield 2026 * |
1.12% | Yield 2027 * | 1.3% |
Last Transcript: Eurofins Scientific SE
| 1 day | +0.43% | ||
| 1 week | +3.34% | ||
| Current month | +1.08% | ||
| 1 month | +9.34% | ||
| 3 months | -0.20% | ||
| 6 months | -4.36% | ||
| Current year | +11.06% |
| 1 week | 66.6 |  | 70.12 |
| 1 month | 61.44 | | 70.28 |
| Current year | 56.84 | | 74.32 |
| 1 year | 54.86 | | 74.32 |
| 3 years | 39.47 | | 74.32 |
| 5 years | 39.47 | | 127.68 |
| 10 years | 29.82 | | 127.68 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gilles Martin
CEO | Chief Executive Officer | 63 | 01/01/1987 |
Laurent Lebras
DFI | Director of Finance/CFO | - | 01/01/2015 |
Christian Wurst
PRN | Corporate Officer/Principal | 53 | 01/10/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Gilles Martin
CHM | Chairman | 63 | 01/01/1987 |
Yves-Loïc Martin
BRD | Director/Board Member | 60 | 01/01/2015 |
Valérie Hanote
BRD | Director/Board Member | 60 | 01/01/1990 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04-27 | Buy | 700 | 0.0004% | |||
| 04-19 | Sell | Executive/Senior Manager | 500 | 0.0003% | ||
| 04-19 | Fiscal year | Chief Financial Officer | 6,000 | 0.0033% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.43% | +3.34% | +14.96% | +17.98% | 13.8B | |
| -0.17% | +1.47% | +3.16% | +7.43% | 50.35B | |
| -0.11% | -2.67% | +388.48% | +594.08% | 39.32B | |
| +0.18% | +2.45% | +32.41% | -5.69% | 34.69B | |
| +1.33% | +3.06% | +15.36% | +57.21% | 34.08B | |
| +1.68% | -1.40% | +4.23% | +27.34% | 26.63B | |
| +0.08% | -4.00% | - | - | 16.49B | |
| -0.50% | +0.22% | +70.50% | +115.54% | 15.31B | |
| +0.62% | +1.90% | +15.83% | -31.19% | 12.87B | |
| +0.93% | -1.88% | +1,412.63% | +653.46% | 11.71B | |
| Average | +0.44% | -1.00% | +217.51% | +159.57% | 25.53B | |
| Weighted average by Cap. | +0.38% | -0.60% | +147.54% | +148.62% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 7.6B 8.69B 7.01B 6.44B 12.21B 836B 12.42B 83.7B 32.84B 409B 32.64B 31.93B 1,409B | 8.07B 9.24B 7.45B 6.85B 12.97B 889B 13.2B 88.92B 34.89B 434B 34.68B 33.92B 1,497B |
| Net income | 517M 591M 477M 438M 830M 56.86B 844M 5.69B 2.23B 27.79B 2.22B 2.17B 95.8B | 676M 773M 624M 573M 1.09B 74.41B 1.1B 7.45B 2.92B 36.37B 2.9B 2.84B 125B |
| Net Debt | 3.44B 3.94B 3.18B 2.92B 5.53B 379B 5.63B 37.91B 14.87B 185B 14.78B 14.46B 638B | 3.08B 3.53B 2.85B 2.62B 4.96B 339B 5.04B 33.97B 13.33B 166B 13.25B 12.96B 572B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/07/26 | €69.30 | +0.43% | 273,072 |
| 14/07/26 | €69.00 | -0.72% | 225,880 |
| 13/07/26 | €69.50 | +0.78% | 151,866 |
| 10/07/26 | €68.96 | +0.23% | 233,361 |
| 09/07/26 | €68.80 | +2.59% | 280,414 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ERF Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
